John Barrie Ward

John Barrie Ward is currently a Director at ADC Products (UK) Ltd. and ADC Therapeutics (UK) Ltd. He previously held positions as Chairman & Chief Executive Officer at Virus Research Institute, Inc., Chief Executive Officer at KuDOS Pharmaceuticals Ltd., Chairman at CellCentric Ltd. (2012-2013), Chairman at ImmunoBiology Ltd., Non-Executive Chairman at London Genetics Ltd., Director at AVANT Immunotherapeutics, Inc., Non-Executive Director at Biotica Technology Ltd., Independent Non-Executive Director at Pharming Group NV (2007-2021), Director at Cancer Research Technology Ltd., Studies Director & Member-Microbiology Division at The National Institute For Medical Research, Non-Executive Director at BerGenBio ASA, Director-Microbiology Division at Glaxo Research Laboratories (1984-1994), Non-Executive Director at ADC Therapeutics SA, Director at Spirogen SARL, and Principal at AstraZeneca AB. He obtained undergraduate and doctorate degrees from the University of Bath.